Yoshiaki Kawano is currently Value Evidence Lead, Specialty, in Value Evidence and Outcome, Japan Medical and Development, GSK, Japan. Yoshiaki received a Doctor of Medical Science degree from the Kumamoto University Graduate School of Medicine in 2001, thereafter working as Research Associate in Molecular Embryology and Genetics at Kumamoto University and Research Associate and Senior Research Officer in Cancer Medicine and in Surgery and Cancer, respectively, at Imperial College London. He worked as Assistant Professor and Lecturer in the Department of Urology at Kumamoto University before joining GSK in 2017, taking on roles of Medical Expert in Speciality General Care, Department Manager for CEP and Pipeline, and Regional Oncology Lead, Women’s Cancer, before moving into his current role in 2022.
Yoshiaki Kawano is currently Value Evidence Lead, Specialty, in Value Evidence and Outcome, Japan Medical and Development, GSK, Japan. Yoshiaki received a Doctor of Medical Science degree from the Kumamoto University Graduate School of Medicine in 2001, thereafter working as Research Associate in Molecular Embryology and Genetics at Kumamoto University and Research Associate and Senior Research Officer in Cancer Medicine and in Surgery and Cancer, respectively, at Imperial College London. He worked as Assistant Professor and Lecturer in the Department of Urology at Kumamoto University before joining GSK in 2017, taking on roles of Medical Expert in Speciality General Care, Department Manager for CEP and Pipeline, and Regional Oncology Lead, Women’s Cancer, before moving into his current role in 2022.